Click for best price
NSAIDs Market Size, Share 2022
Market Analysis and Insights: Global NSAIDs Market
The global NSAIDs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NSAIDs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NSAIDs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NSAIDs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NSAIDs market.
Global NSAIDs Scope and Market Size
NSAIDs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
By Company
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes NSAIDs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of NSAIDs, with price, sales, revenue, and global market share of NSAIDs from 2019 to 2022.
Chapter 3, the NSAIDs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NSAIDs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs.
Chapter 13, 14, and 15, to describe NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 NSAIDs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global NSAIDs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 NSAIDs Product Introduction
1.2 Market by Type
1.2.1 Global NSAIDs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 Market by Application
1.3.1 Global NSAIDs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other Disease Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global NSAIDs Sales Estimates and Forecasts 2017-2028
2.2 Global NSAIDs Revenue Estimates and Forecasts 2017-2028
2.3 Global NSAIDs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global NSAIDs Sales by Region
2.4.1 Global NSAIDs Sales by Region (2017-2022)
2.4.2 Global Sales NSAIDs by Region (2023-2028)
2.5 Global NSAIDs Revenue by Region
2.5.1 Global NSAIDs Revenue by Region (2017-2022)
2.5.2 Global NSAIDs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global NSAIDs Sales by Manufacturers
3.1.1 Global Top NSAIDs Manufacturers by Sales (2017-2022)
3.1.2 Global NSAIDs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of NSAIDs in 2021
3.2 Global NSAIDs Revenue by Manufacturers
3.2.1 Global NSAIDs Revenue by Manufacturers (2017-2022)
3.2.2 Global NSAIDs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by NSAIDs Revenue in 2021
3.3 Global NSAIDs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global NSAIDs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global NSAIDs Sales by Type
4.1.1 Global NSAIDs Historical Sales by Type (2017-2022)
4.1.2 Global NSAIDs Forecasted Sales by Type (2023-2028)
4.1.3 Global NSAIDs Sales Market Share by Type (2017-2028)
4.2 Global NSAIDs Revenue by Type
4.2.1 Global NSAIDs Historical Revenue by Type (2017-2022)
4.2.2 Global NSAIDs Forecasted Revenue by Type (2023-2028)
4.2.3 Global NSAIDs Revenue Market Share by Type (2017-2028)
4.3 Global NSAIDs Price by Type
4.3.1 Global NSAIDs Price by Type (2017-2022)
4.3.2 Global NSAIDs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global NSAIDs Sales by Application
5.1.1 Global NSAIDs Historical Sales by Application (2017-2022)
5.1.2 Global NSAIDs Forecasted Sales by Application (2023-2028)
5.1.3 Global NSAIDs Sales Market Share by Application (2017-2028)
5.2 Global NSAIDs Revenue by Application
5.2.1 Global NSAIDs Historical Revenue by Application (2017-2022)
5.2.2 Global NSAIDs Forecasted Revenue by Application (2023-2028)
5.2.3 Global NSAIDs Revenue Market Share by Application (2017-2028)
5.3 Global NSAIDs Price by Application
5.3.1 Global NSAIDs Price by Application (2017-2022)
5.3.2 Global NSAIDs Price Forecast by Application (2023-2028)
6 North America
6.1 North America NSAIDs Market Size by Type
6.1.1 North America NSAIDs Sales by Type (2017-2028)
6.1.2 North America NSAIDs Revenue by Type (2017-2028)
6.2 North America NSAIDs Market Size by Application
6.2.1 North America NSAIDs Sales by Application (2017-2028)
6.2.2 North America NSAIDs Revenue by Application (2017-2028)
6.3 North America NSAIDs Market Size by Country
6.3.1 North America NSAIDs Sales by Country (2017-2028)
6.3.2 North America NSAIDs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe NSAIDs Market Size by Type
7.1.1 Europe NSAIDs Sales by Type (2017-2028)
7.1.2 Europe NSAIDs Revenue by Type (2017-2028)
7.2 Europe NSAIDs Market Size by Application
7.2.1 Europe NSAIDs Sales by Application (2017-2028)
7.2.2 Europe NSAIDs Revenue by Application (2017-2028)
7.3 Europe NSAIDs Market Size by Country
7.3.1 Europe NSAIDs Sales by Country (2017-2028)
7.3.2 Europe NSAIDs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific NSAIDs Market Size by Type
8.1.1 Asia Pacific NSAIDs Sales by Type (2017-2028)
8.1.2 Asia Pacific NSAIDs Revenue by Type (2017-2028)
8.2 Asia Pacific NSAIDs Market Size by Application
8.2.1 Asia Pacific NSAIDs Sales by Application (2017-2028)
8.2.2 Asia Pacific NSAIDs Revenue by Application (2017-2028)
8.3 Asia Pacific NSAIDs Market Size by Region
8.3.1 Asia Pacific NSAIDs Sales by Region (2017-2028)
8.3.2 Asia Pacific NSAIDs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America NSAIDs Market Size by Type
9.1.1 Latin America NSAIDs Sales by Type (2017-2028)
9.1.2 Latin America NSAIDs Revenue by Type (2017-2028)
9.2 Latin America NSAIDs Market Size by Application
9.2.1 Latin America NSAIDs Sales by Application (2017-2028)
9.2.2 Latin America NSAIDs Revenue by Application (2017-2028)
9.3 Latin America NSAIDs Market Size by Country
9.3.1 Latin America NSAIDs Sales by Country (2017-2028)
9.3.2 Latin America NSAIDs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa NSAIDs Market Size by Type
10.1.1 Middle East and Africa NSAIDs Sales by Type (2017-2028)
10.1.2 Middle East and Africa NSAIDs Revenue by Type (2017-2028)
10.2 Middle East and Africa NSAIDs Market Size by Application
10.2.1 Middle East and Africa NSAIDs Sales by Application (2017-2028)
10.2.2 Middle East and Africa NSAIDs Revenue by Application (2017-2028)
10.3 Middle East and Africa NSAIDs Market Size by Country
10.3.1 Middle East and Africa NSAIDs Sales by Country (2017-2028)
10.3.2 Middle East and Africa NSAIDs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Novacap
11.2.1 Novacap Corporation Information
11.2.2 Novacap Overview
11.2.3 Novacap NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novacap NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novacap Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Cigna
11.6.1 Cigna Corporation Information
11.6.2 Cigna Overview
11.6.3 Cigna NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cigna NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cigna Recent Developments
11.7 Geri-Care Pharmaceuticals
11.7.1 Geri-Care Pharmaceuticals Corporation Information
11.7.2 Geri-Care Pharmaceuticals Overview
11.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Geri-Care Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Geri-Care Pharmaceuticals Recent Developments
11.8 Perrigo Company
11.8.1 Perrigo Company Corporation Information
11.8.2 Perrigo Company Overview
11.8.3 Perrigo Company NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Perrigo Company NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Perrigo Company Recent Developments
11.9 Kopran
11.9.1 Kopran Corporation Information
11.9.2 Kopran Overview
11.9.3 Kopran NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Kopran NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kopran Recent Developments
11.10 Merck Sharp & Dohme
11.10.1 Merck Sharp & Dohme Corporation Information
11.10.2 Merck Sharp & Dohme Overview
11.10.3 Merck Sharp & Dohme NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Merck Sharp & Dohme NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merck Sharp & Dohme Recent Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Corporation Information
11.11.2 Sun Pharmaceutical Industries Overview
11.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Industries NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Industries Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Corporation Information
11.12.2 GlaxoSmithKline Overview
11.12.3 GlaxoSmithKline NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 GlaxoSmithKline NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GlaxoSmithKline Recent Developments
11.13 Reddy Pharmaceuticals
11.13.1 Reddy Pharmaceuticals Corporation Information
11.13.2 Reddy Pharmaceuticals Overview
11.13.3 Reddy Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Reddy Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Reddy Pharmaceuticals Recent Developments
11.14 Verywell
11.14.1 Verywell Corporation Information
11.14.2 Verywell Overview
11.14.3 Verywell NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Verywell NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Verywell Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 NSAIDs Industry Chain Analysis
12.2 NSAIDs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 NSAIDs Production Mode & Process
12.4 NSAIDs Sales and Marketing
12.4.1 NSAIDs Sales Channels
12.4.2 NSAIDs Distributors
12.5 NSAIDs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 NSAIDs Industry Trends
13.2 NSAIDs Market Drivers
13.3 NSAIDs Market Challenges
13.4 NSAIDs Market Restraints
14 Key Findings in The Global NSAIDs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global NSAIDs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Aspirin
Table 3. Major Manufacturers of Ibuprofen
Table 4. Major Manufacturers of Naproxen
Table 5. Major Manufacturers of Nabumetone
Table 6. Major Manufacturers of Others
Table 7. Global NSAIDs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global NSAIDs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 10. Global NSAIDs Sales Market Share by Region (2017-2022)
Table 11. Global NSAIDs Sales by Region (2023-2028) & (K Pcs)
Table 12. Global NSAIDs Sales Market Share by Region (2023-2028)
Table 13. Global NSAIDs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global NSAIDs Revenue Market Share by Region (2017-2022)
Table 15. Global NSAIDs Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global NSAIDs Revenue Market Share by Region (2023-2028)
Table 17. Global NSAIDs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global NSAIDs Sales Share by Manufacturers (2017-2022)
Table 19. Global NSAIDs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global NSAIDs Revenue Share by Manufacturers (2017-2022)
Table 21. NSAIDs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs as of 2021)
Table 24. NSAIDs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers NSAIDs Product Offered
Table 26. Date of Manufacturers Enter into NSAIDs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 29. Global NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 30. Global NSAIDs Sales Share by Type (2017-2022)
Table 31. Global NSAIDs Sales Share by Type (2023-2028)
Table 32. Global NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global NSAIDs Revenue Share by Type (2017-2022)
Table 35. Global NSAIDs Revenue Share by Type (2023-2028)
Table 36. NSAIDs Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global NSAIDs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 39. Global NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 40. Global NSAIDs Sales Share by Application (2017-2022)
Table 41. Global NSAIDs Sales Share by Application (2023-2028)
Table 42. Global NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global NSAIDs Revenue Share by Application (2017-2022)
Table 45. Global NSAIDs Revenue Share by Application (2023-2028)
Table 46. NSAIDs Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global NSAIDs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 49. North America NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 50. North America NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 53. North America NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 54. North America NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 57. North America NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 58. North America NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America NSAIDs Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe NSAIDs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific NSAIDs Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific NSAIDs Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific NSAIDs Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America NSAIDs Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa NSAIDs Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa NSAIDs Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa NSAIDs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Bayer Corporation Information
Table 109. Bayer Description and Major Businesses
Table 110. Bayer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Bayer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bayer Recent Developments
Table 113. Novacap Corporation Information
Table 114. Novacap Description and Major Businesses
Table 115. Novacap NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Novacap NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novacap Recent Developments
Table 118. Abbott Corporation Information
Table 119. Abbott Description and Major Businesses
Table 120. Abbott NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Abbott NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Abbott Recent Developments
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Pfizer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Pfizer Recent Developments
Table 128. Johnson & Johnson Corporation Information
Table 129. Johnson & Johnson Description and Major Businesses
Table 130. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. Johnson & Johnson NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Johnson & Johnson Recent Developments
Table 133. Cigna Corporation Information
Table 134. Cigna Description and Major Businesses
Table 135. Cigna NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Cigna NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Cigna Recent Developments
Table 138. Geri-Care Pharmaceuticals Corporation Information
Table 139. Geri-Care Pharmaceuticals Description and Major Businesses
Table 140. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Geri-Care Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Geri-Care Pharmaceuticals Recent Developments
Table 143. Perrigo Company Corporation Information
Table 144. Perrigo Company Description and Major Businesses
Table 145. Perrigo Company NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Perrigo Company NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Perrigo Company Recent Developments
Table 148. Kopran Corporation Information
Table 149. Kopran Description and Major Businesses
Table 150. Kopran NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Kopran NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Kopran Recent Developments
Table 153. Merck Sharp & Dohme Corporation Information
Table 154. Merck Sharp & Dohme Description and Major Businesses
Table 155. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 156. Merck Sharp & Dohme NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Merck Sharp & Dohme Recent Developments
Table 158. Sun Pharmaceutical Industries Corporation Information
Table 159. Sun Pharmaceutical Industries Description and Major Businesses
Table 160. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 161. Sun Pharmaceutical Industries NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Sun Pharmaceutical Industries Recent Developments
Table 163. GlaxoSmithKline Corporation Information
Table 164. GlaxoSmithKline Description and Major Businesses
Table 165. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 166. GlaxoSmithKline NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. GlaxoSmithKline Recent Developments
Table 168. Reddy Pharmaceuticals Corporation Information
Table 169. Reddy Pharmaceuticals Description and Major Businesses
Table 170. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 171. Reddy Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Reddy Pharmaceuticals Recent Developments
Table 173. Verywell Corporation Information
Table 174. Verywell Description and Major Businesses
Table 175. Verywell NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 176. Verywell NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Verywell Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. NSAIDs Distributors List
Table 181. NSAIDs Customers List
Table 182. NSAIDs Market Trends
Table 183. NSAIDs Market Drivers
Table 184. NSAIDs Market Challenges
Table 185. NSAIDs Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAIDs Product Picture
Figure 3. Global NSAIDs Market Share by Type in 2021 & 2028
Figure 3. Aspirin Product Picture
Figure 4. Ibuprofen Product Picture
Figure 5. Naproxen Product Picture
Figure 6. Nabumetone Product Picture
Figure 7. Others Product Picture
Figure 8. Global NSAIDs Market Share by Application in 2021 & 2028
Figure 9. Back Pain Treatment
Figure 10. Osteoarthritis Treatment
Figure 11. Other Disease Treatment
Figure 12. NSAIDs Report Years Considered
Figure 13. Global NSAIDs Sales 2017-2028 (K Pcs)
Figure 14. Global NSAIDs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global NSAIDs Revenue 2017-2028 (US$ Million)
Figure 16. Global NSAIDs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global NSAIDs Sales Market Share by Region (2017-2022)
Figure 18. Global NSAIDs Sales Market Share by Region (2023-2028)
Figure 19. North America NSAIDs Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America NSAIDs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe NSAIDs Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe NSAIDs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific NSAIDs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific NSAIDs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America NSAIDs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America NSAIDs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa NSAIDs Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa NSAIDs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The NSAIDs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of NSAIDs in the World: Market Share by NSAIDs Revenue in 2021
Figure 31. Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global NSAIDs Sales Market Share by Type (2017-2028)
Figure 33. Global NSAIDs Revenue Market Share by Type (2017-2028)
Figure 34. Global NSAIDs Sales Market Share by Application (2017-2028)
Figure 35. Global NSAIDs Revenue Market Share by Application (2017-2028)
Figure 36. North America NSAIDs Sales Market Share by Type (2017-2028)
Figure 37. North America NSAIDs Revenue Market Share by Type (2017-2028)
Figure 38. North America NSAIDs Sales Market Share by Application (2017-2028)
Figure 39. North America NSAIDs Revenue Market Share by Application (2017-2028)
Figure 40. North America NSAIDs Sales Share by Country (2017-2028)
Figure 41. North America NSAIDs Revenue Share by Country (2017-2028)
Figure 42. U.S. NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 43. Canada NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 44. Europe NSAIDs Sales Market Share by Type (2017-2028)
Figure 45. Europe NSAIDs Revenue Market Share by Type (2017-2028)
Figure 46. Europe NSAIDs Sales Market Share by Application (2017-2028)
Figure 47. Europe NSAIDs Revenue Market Share by Application (2017-2028)
Figure 48. Europe NSAIDs Sales Share by Country (2017-2028)
Figure 49. Europe NSAIDs Revenue Share by Country (2017-2028)
Figure 50. Germany NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 51. France NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 53. Italy NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 54. Russia NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific NSAIDs Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific NSAIDs Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific NSAIDs Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific NSAIDs Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific NSAIDs Sales Share by Region (2017-2028)
Figure 60. Asia Pacific NSAIDs Revenue Share by Region (2017-2028)
Figure 61. China NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 62. Japan NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 64. India NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 65. Australia NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America NSAIDs Sales Market Share by Type (2017-2028)
Figure 72. Latin America NSAIDs Revenue Market Share by Type (2017-2028)
Figure 73. Latin America NSAIDs Sales Market Share by Application (2017-2028)
Figure 74. Latin America NSAIDs Revenue Market Share by Application (2017-2028)
Figure 75. Latin America NSAIDs Sales Share by Country (2017-2028)
Figure 76. Latin America NSAIDs Revenue Share by Country (2017-2028)
Figure 77. Mexico NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa NSAIDs Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa NSAIDs Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa NSAIDs Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa NSAIDs Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa NSAIDs Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa NSAIDs Revenue Share by Country (2017-2028)
Figure 86. Turkey NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E NSAIDs Revenue (2017-2028) & (US$ Million)
Figure 89. NSAIDs Value Chain
Figure 90. NSAIDs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
